National Institutes of Health: Intestinal Diseases trials

The registry lists 15 Intestinal Diseases studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 4Phase 2 2Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable ImmunodeficiencyCompletedNCT02199496Phase 1/2Results posted
• NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNCT00936585Not applicableResults posted
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1/2Results posted
• The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel DiseaseWithdrawnNCT05652491
• Natural History of Intestinal Inflammation in People With Primary Immune DysregulationsWithdrawnNCT03278912
• Antibody Treatment for Advanced Celiac DiseaseCompletedNCT01893775Phase 1
• Bone Marrow Stromal Cells for Inflammatory Bowel DiseasesTerminatedNCT01851343Phase 1
• Telomere Repair Gene Mutation in Inflammatory Bowel DiseaseCompletedNCT00353639
• Genetic Studies of Inflammatory Bowel DiseaseCompletedNCT00340444
• Infectious Agents in Pediatric Crohn'sCompletedNCT00237055
• Collection of Specimens for Study of Inflammatory Bowel DiseaseCompletedNCT00086554
• A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel DiseaseCompletedNCT00035074Not applicable
• Treatment of Functional Bowel DisordersCompletedNCT00006157Phase 3
• Genetic Study of SitosterolemiaCompletedNCT00004481
• Parasitic Infections of the Gastrointestinal TractTerminatedNCT00001162